SELLAS Life Sciences (SLS) Equity Ratio (2019 - 2024)
Historic Equity Ratio for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to 0.6.
- SELLAS Life Sciences' Equity Ratio rose 22668.52% to 0.6 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.6, marking a year-over-year increase of 22668.52%. This contributed to the annual value of 1.28 for FY2023, which is 65369.7% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Equity Ratio stood at 0.6, which was up 22668.52% from 0.19 recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Equity Ratio high stood at 0.77 for Q4 2021, and its period low was 1.28 during Q4 2023.
- Over the past 5 years, SELLAS Life Sciences' median Equity Ratio value was 0.45 (recorded in 2023), while the average stood at 0.33.
- Per our database at Business Quant, SELLAS Life Sciences' Equity Ratio tumbled by 65369.7% in 2023 and then soared by 22668.52% in 2024.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Equity Ratio stood at 0.61 in 2020, then rose by 27.53% to 0.77 in 2021, then crashed by 70.09% to 0.23 in 2022, then plummeted by 653.7% to 1.28 in 2023, then soared by 146.75% to 0.6 in 2024.
- Its last three reported values are 0.6 in Q3 2024, 0.19 for Q2 2024, and 0.4 during Q1 2024.